Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab.

Leen VerleyeDiego Castanares-ZapateroCarl DevosCindy De GendtGeert SilversmitNancy Van DammeFrank HulstaertNancy ThiryMattias Neyt

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)

Despite a rise in the use of debulking surgery and the introduction of bevacizumab into clinical practice, no improvement in 3 year survival probability was observed for patients with advanced ovarian cancer in Belgium.

Keyphrases

minimally invasive
coronary artery bypass
neoadjuvant chemotherapy
clinical practice
metastatic colorectal cancer
surgical site infection
free survival
squamous cell carcinoma
radiation therapy
percutaneous coronary intervention
acute coronary syndrome
locally advanced